Alyeska Investment Group’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-139,343
Closed -$4.46M 595
2023
Q3
$4.46M Buy
139,343
+7,544
+6% +$291K 0.03% 348
2023
Q2
$5.78M Buy
131,799
+69,793
+113% +$3.22M 0.04% 322
2023
Q1
$2.75M Sell
62,006
-51,527
-45% -$2.28M 0.02% 335
2022
Q4
$4.51M Buy
113,533
+62,986
+125% +$2.62M 0.05% 263
2022
Q3
$2.33M Buy
+50,547
New +$2.48M 0.03% 315
2020
Q4
Sell
-149,849
Closed -$6.88M 558
2020
Q3
$6.88M Buy
149,849
+104,839
+233% +$4.86M 0.1% 224
2020
Q2
$1.97M Buy
+45,010
New +$2.02M 0.03% 356
2018
Q2
Sell
-166,526
Closed -$2.51M 494
2018
Q1
$2.51M Buy
166,526
+17,926
+12% +$317K 0.02% 335
2017
Q4
$2.85M Buy
+148,600
New +$2.84M 0.02% 303

Other funds holding KIDS

Alyeska Investment Group's KIDS Position: Q4 2023 in Review

Alyeska Investment Group sold out of OrthoPediatrics (KIDS) in Q4 2023, closing a stake of 139,343 shares — an estimated $4.46M sold.

Alyeska Investment Group first reported a position in KIDS in Q4 2017 and held it in 9 quarters. The position peaked at $6.88M in Q3 2020. 129 funds tracked by Wall St. Rank hold KIDS as of Q4 2023.

  • Alyeska Investment Group reported no remaining OrthoPediatrics position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 139,343 OrthoPediatrics shares in Q4 2023, an estimated $4.46M.
  • Alyeska Investment Group first reported a position in OrthoPediatrics in Q4 2017 and held it in 9 quarters.
  • Alyeska Investment Group's OrthoPediatrics position peaked at $6.88M in Q3 2020.
  • 129 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.